Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12,733,410
-
Total 13F shares
-
2,122,428
-
Share change
-
+242,871
-
Total reported value
-
$44,038,752
-
Price per share
-
$20.75
-
Number of holders
-
51
-
Value change
-
+$5,588,999
-
Number of buys
-
36
-
Number of sells
-
12
Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2018
As of 30 Jun 2018,
IRADIMED CORP - Common Stock (IRMD) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,122,428 shares.
The largest 10 holders included
AMERIPRISE FINANCIAL INC, BlackRock Inc., VANGUARD GROUP INC, Ranger Investment Management, L.P., Mondrian Investment Partners LTD, CADENCE CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, Russell Investments Group, Ltd., Menta Capital LLC, and Boston Partners.
This page lists
51
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.